Cargando…

Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis

BACKGROUND: The diagnostic accuracy of cerebrospinal fluid oligoclonal bands (CSF-OCB) detected by isoelectric focusing (IEF) in patients with multiple sclerosis (MS) was evaluated in our study. METHODS: Three hundred and twenty-one patients with MS and other central nervous system (CNS) immune medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernitsas, Evanthia, Khan, Omar, Razmjou, Sara, Tselis, Alexandros, Bao, Fen, Caon, Christina, Millis, Scott, Seraji-Bozorgzad, Navid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519077/ https://www.ncbi.nlm.nih.gov/pubmed/28727770 http://dx.doi.org/10.1371/journal.pone.0181431

Ejemplares similares

Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases
por: Memon, Anza B., et al.
Publicado: (2018)

Structural and Neuronal Integrity Measures of Fatigue Severity in Multiple Sclerosis
por: Bernitsas, Evanthia, et al.
Publicado: (2017)

Characterizing Fatigue-Related White Matter Changes in MS: A Proton Magnetic Resonance Spectroscopy Study
por: Yarraguntla, Kalyan, et al.
Publicado: (2019)

The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20‐Year Data from the U.S. Glatiramer Acetate Extension Study
por: Khan, Omar, et al.
Publicado: (2016)

Optical Coherence Tomography in Chronic Relapsing Inflammatory Optic Neuropathy, Neuromyelitis Optica and Multiple Sclerosis: A Comparative Study
por: Eslami, Maziar, et al.
Publicado: (2022)

Effect of Obesity on Retinal Integrity in African Americans and Caucasian Americans With Relapsing Multiple Sclerosis
por: Rube, Jacob, et al.
Publicado: (2021)

From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
por: Raghib, Muhammad Faraz, et al.
Publicado: (2023)

Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
por: Bross, Madeline, et al.
Publicado: (2020)

Pathophysiology and Imaging Diagnosis of Demyelinating Disorders
por: Bernitsas, Evanthia
Publicado: (2018)

Imaging of the Spinal Cord in Multiple Sclerosis: Past, Present, Future
por: Chen, Yongsheng, et al.
Publicado: (2020)

Cerebrospinal fluid in multiple sclerosis
por: Rammohan, Kottil W.
Publicado: (2009)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

The Emerging Role of Scalogram-Based Convolutional Neural Network in the Diagnosis of Epileptic Seizures
por: Bernitsas, Evanthia
Publicado: (2021)

PENETRATION OF RADIOACTIVE SODIUM AND CHLORIDE INTO CEREBROSPINAL FLUID AND AQUEOUS HUMOR
por: Wang, Jun-Ch'uan
Publicado: (1948)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
por: Lo Sasso, Bruna, et al.
Publicado: (2019)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
por: Bruijstens, Arlette L, et al.
Publicado: (2022)

Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007)

The radiodensity of cerebrospinal fluid and vitreous humor as indicator of the time since death
por: Koopmanschap, Desirée H. J. L. M., et al.
Publicado: (2016)

Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis
por: Martynova, Ekaterina, et al.
Publicado: (2020)

Neuromyelitis Optica in a Young Woman With Tuberous Sclerosis: Is There an Association?
por: Elkhooly, Mahmoud, et al.
Publicado: (2022)

Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis
por: Ehling, Rainer, et al.
Publicado: (2011)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Cerebrospinal fluid GAP-43 in early multiple sclerosis
por: Rot, U, et al.
Publicado: (2018)

The cerebrospinal fluid in multiple sclerosis: far beyond the bands
por: Domingues, Renan Barros, et al.
Publicado: (2017)

Cerebrospinal fluid cells immune landscape in multiple sclerosis
por: Li, Zijian, et al.
Publicado: (2021)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis
por: Callegari, Ilaria, et al.
Publicado: (2023)

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023)

From Postural Orthostatic Tachycardia Syndrome to Radiologically Isolated Syndrome
por: Tripathi, Richa, et al.
Publicado: (2018)

Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis
por: Dujmovic, Irena
Publicado: (2011)

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
por: Liu, Shilian, et al.
Publicado: (2009)

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis
por: da Gama, Paulo Diniz, et al.
Publicado: (2015)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
por: Albanese, Maria, et al.
Publicado: (2016)

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis
por: Sandelius, Åsa, et al.
Publicado: (2019)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
por: Ganapathy Subramanian, Ranjani, et al.
Publicado: (2021)

Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic
por: Wong, Jamie K, et al.
Publicado: (2023)

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
por: Nogueras, L., et al.
Publicado: (2019)

Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid
por: Kaushik, Deepak K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v6mhmu3u5ob07fmhi15s92n73l